Monitoring genes and health after kidney transplant
Part of Lungs & breathing clinical trials.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be the recipient of a kidney transplant (first transplant or a repeat), from a living or deceased donor
- You (or your guardian) must be able to understand and sign informed consent
- You (or your guardian) must be able to follow the study schedule and instructions
- You must not be planning a transplant that includes other organs besides the kidney
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This study looks at the genes of people who have had or will have a kidney transplant. It aims to learn how genetic information might help improve transplant care over time. Participants will give blood, urine, stool, and possibly kidney tissue samples for research.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study checks samples from people after a kidney transplant to better understand how treatment is working at a biological (molecular) level. It may help doctors improve follow-up care and therapy over time.
This study tests whether a special blood test can help monitor your new kidney after transplant. It may help doctors spot problems earlier and improve kidney health.
This study looks at how genes in the kidney change when the body might be rejecting the transplant. By studying these genes, doctors hope to find better ways to detect kidney rejection early and help keep the kidney healthy longer.
Hear when a new Acute Rejection (AR) of Transplanted Kidney trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.